Lv2
184 积分 2024-09-15 加入
Selective delivery of doxorubicin by novel stimuli-sensitive nano-ferritins overcomes tumor refractoriness
6天前
已关闭
Chemically Engineered Affinity Protein Drugs for Covalent Targeted Cancer Therapy
1个月前
已完结
Synergistic SuFEx-Driven Covalent Cancer Therapy Using a HER2/EGFR Bivalent Affinity Protein Drug
1个月前
已完结
H-ferritin engineered nanoplatform reprograms metabolism and immunity for glioblastoma immunotherapy
2个月前
已完结
Engineering a HER2-specific antibody–drug conjugate to increase lysosomal delivery and therapeutic efficacy
2个月前
已完结
Radionuclide Therapy of HER2-Expressing Xenografts Using [177Lu]Lu-ABY-027 Affibody Molecule Alone and in Combination with Trastuzumab
2个月前
已关闭
Biomimetic Tertiary Lymphoid Structures with Microporous Annealed Particle Scaffolds for Cancer Postoperative Therapy
2个月前
已完结
Ferritin nanocage with intrinsically disordered proteins and affibody: A platform for tumor targeting with extended pharmacokinetics
3个月前
已完结
Dynamic Size-Change Nanovaccine for Enhancing Lymph Node Deep Penetration and Eliciting Robust Antitumor Immune Responses
4个月前
已完结
Dynamic Size-Change Nanovaccine for Enhancing Lymph Node Deep Penetration and Eliciting Robust Antitumor Immune Responses
4个月前
已完结
皖公网安备34019202002308
